SHR # 2226 :: SFH: New Anti-Heart-Attack / Anti-Stroke Drug Focuses on the Microbiome :: Cholesterol lowering drugs have done little to prevent heart attack and stroke, but this new drug appears to not only target a completely different pathway but also to potentially prevent the occurrence of ischemic events in the heart and brain. Scientist at the Cleveland Clinic have come up with a new drug that targets the gut microbes of patients at high risk of heart attack and stroke and his has nothing to do with cholesterol. ::